Treatment for Opiate Addiction

Does Medicare Cover Suboxone

Does Medicare cover Suboxone? Part D paid 149,372 Suboxone claims in 2024. That CMS figure reflects program spending, not your own cost or access.

Reviewing insurance coverage
the United States at dusk

In 2024, Part D paid 149,372 claims for Suboxone (buprenorphine with naloxone) at a total of $70,660,251, or $473 per claim on average. Those figures come from the CMS Medicare and Medicaid Spending by Drug dataset, as of November 15, 2026, and they are national totals for the program, not a promise about any one person's plan or a guarantee of access near you.

Coverage is not the same as access. A plan may list a drug on its formulary while requiring prior authorization, or a pharmacy may not stock it. Medicare Part D spending data shows what was paid, not what a specific plan will approve for you. If you are helping someone sort this out, the practical step is to call the number on the back of the Medicare card and ask about the exact product and dose.

Family support

What the Part D data shows

Suboxone had 149,372 claims, down from 199,315 the year before, with $70,660,251 in total spending and an average of $473 per claim. Zubsolv, another buprenorphine with naloxone product, had 49,425 claims, down from 52,836, at $25,785,738 total and $522 per claim.

Sublocade, a monthly buprenorphine injection, had 24,923 claims, up from 18,174, at $50,486,306 total and $2,026 per claim.

Source: CMS Medicare and Medicaid Spending by Drug (data.cms.gov), read on 2026-11-15. United States (national totals). Claims are prescriptions paid by the program; spending is before manufacturer rebates. Use does not imply CMS endorsement.
MedicationProgramYearPaid claimsTotal spending
Suboxone (buprenorphine hcl/naloxone hcl)Medicare Part D2024149,372$70.7 million
Sublocade (buprenorphine)Medicare Part D202424,923$50.5 million
Vivitrol (naltrexone microspheres)Medicare Part D202444,521$73.1 million
Zubsolv (buprenorphine hcl/naloxone hcl)Medicare Part D202449,425$25.8 million

Cost figures and your treatment plan

Across the SAMHSA-listed facilities we track, 7,748 offer buprenorphine and 5,492 accept Medicare, and 4,960 offer both. That matters because a prescriber and a pharmacy both need to be in the picture. When you call a program, ask whether they prescribe buprenorphine and whether they bill Medicare, and ask the plan separately about the specific product.

If a plan denies a prior authorization, then you can ask for the reason in writing and ask what alternative is covered, because Part D plans vary by formulary and tier. If the person needs a level of care such as detox or residential treatment, then the Medicare benefit and the facility's own admission process both come into play. Checking a program's Medicare acceptance before arranging a ride saves a wasted trip. The state Medicaid program may also be relevant if the person has both Medicare and Medicaid.

Questions to put to a plan or prescriber

  1. Is this specific buprenorphine product on the plan's formulary, and does it require prior authorization or step therapy?
  2. What would my copay be for a one-month supply, and does that change at the deductible or coverage gap?
  3. Does this prescriber accept Medicare assignment, and is there a cost for the visit itself?
  4. If the plan denies coverage, what is the appeal process and what documentation does the prescriber need to send?
  5. Does the pharmacy stock this medication, or will I need to transfer the prescription?
A journal and pen

Limits of this data

These are national Medicare Part D totals from CMS, current as of November 15, 2026, and they describe spending before rebates. They do not show what any individual paid, which plans cover which products, or whether a person's care was appropriate. The facility counts come from SAMHSA FindTreatment.gov listings and reflect what programs report; a listing is not a recommendation or a guarantee of admission. Coverage questions are settled by the plan and the prescriber, not by this page.

Questions people ask

Does Medicare cover Suboxone?

Medicare Part D can cover Suboxone, and in 2024 the program paid 149,372 claims for it. Coverage depends on the plan's formulary and any prior authorization rules, so call the plan with the exact product name. The CMS data shows that payment happened at the program level, not what your own cost would be.

Is buprenorphine covered by Medicare for opioid use disorder?

Yes, Part D has paid for buprenorphine products including Suboxone, Zubsolv, and Sublocade. In 2024, Suboxone alone accounted for 149,372 claims. Among SAMHSA-listed facilities we track, 7,748 offer buprenorphine. A prescriber decides which product is appropriate, and the plan decides what it will pay.

What does Medicare Part D spend on Suboxone?

In 2024, Part D total spending on Suboxone was $70,660,251 across 149,372 claims, an average of $473 per claim. These are national totals before manufacturer rebates, from the CMS drug spending dataset as of November 15, 2026. They are not a prediction of your own cost.

How many treatment facilities accept Medicare?

On our list, 5,492 SAMHSA-listed facilities accept Medicare, and 4,960 of them offer buprenorphine as well. That is out of 8,639 total listings nationally. Listing does not mean a facility has an opening or that it is the right level of care, so call to confirm before you go.

Does Medicare cover methadone for opioid use disorder?

Ask the program how it bills and what your cost would be.

Where to take the next question

If you call on behalf of a loved one, our referral line is available anytime to discuss what exists in your area, including programs that accept Medicare and buprenorphine prescribers. We do not promise coverage or admit anyone. For coverage specifics, the plan and the prescriber decide. Also available is the SAMHSA National Helpline at 1-800-662-4357, and 988 connects to the crisis line.

No cost, no name needed · (855) 705-1373